In vivo quantification of lead in bone with a portable x-ray fluorescence system--methodology and feasibility.
This study was conducted to investigate the methodology and feasibility of developing a portable x-ray fluorescence (XRF) technology to quantify lead (Pb) in bone in vivo. A portable XRF device was set up and optimal settings of voltage, current, and filter combination for bone lead quantification were selected to achieve the lowest detection limit. The minimum radiation dose delivered to the subject was calculated by Monte Carlo simulations. An ultrasound device was used to measure soft tissue thickness to account for signal attenuation, and an alternative method to obtain soft tissue thickness from the XRF spectrum was developed and shown to be equivalent to the ultrasound measurements (intraclass correlation coefficient, ICC = 0.82). We tested the correlation of in vivo bone lead concentrations between the standard KXRF technology and the portable XRF technology. There was a significant correlation between the bone lead concentrations obtained from the standard KXRF technology and those obtained from the portable XRF technology (ICC = 0.65). The detection limit for the portable XRF device was about 8.4 ppm with 2 mm soft tissue thickness. The entrance skin dose delivered to the human subject was about 13 mSv and the total body effective dose was about 1.5 µSv and should pose minimal radiation risk. In conclusion, portable XRF technology can be used for in vivo bone lead measurement with sensitivity comparable to the KXRF technology and good correlation with KXRF measurements.
School of Health Sciences, Purdue University, West Lafayette, IN 47906, USA. hnie@purdue.edu
L H
LH
Nie
S
S
Sanchez
K
K
Newton
L
L
Grodzins
R O
RO
Cleveland
M G
MG
Weisskopf
D001842:Bone and Bones / Q000737:chemistry*; D005240:Feasibility Studies; D006801:Humans; D007854:Lead / Q000032:analysis*; D057230:Limit of Detection; D019047:Phantoms, Imaging; D013052:Spectrometry, X-Ray Emission / Q000295:instrumentation*
D007854:Lead
Phys Med Biol. 2004 Oct 7;49(19):N325-34
15552425
Environ Health Perspect. 1991 Feb;91:49-55
2040251
Environ Res. 1992 Apr;57(2):117-32
1568436
Environ Health Perspect. 1991 Feb;91:33-7
2040248
Psychol Bull. 1979 Mar;86(2):420-8
18839484
Phys Med Biol. 1989 Sep;34(9):1295-300
2798561
Epidemiology. 2008 May;19(3):496-504
18414090
Circulation. 2009 Sep 22;120(12):1056-64
19738141
Phys Med Biol. 2006 Jan 21;51(2):351-60
16394343
Med Phys. 2002 Nov;29(11):2687-91
12462736
Phys Med Biol. 2002 Apr 21;47(8):1399-419
12030563
Epidemiology. 2009 Nov;20(6):831-9
19752734
Environ Health Perspect. 1993 Dec;101(7):598-616
8143593
JAMA. 1996 Feb 7;275(5):363-9
8569015
Phys Med Biol. 1994 Dec;39(12):2263-71
15551552
N Engl J Med. 2003 Apr 17;348(16):1517-26
12700371
Br J Ind Med. 1993 Jul;50(7):637-41
8343425
Pediatrics. 1997 Nov;100(5):856-62
9346987
Environ Health Perspect. 2007 Mar;115(3):483-92
17431502
JAMA. 1996 Apr 17;275(15):1171-6
8609684
J Anal At Spectrom. 2009;24(5):622-626
22798703
Environ Health Perspect. 2007 Mar;115(3):472-82
17431501
J Occup Environ Med. 2005 Mar;47(3):235-43
15761319
JAMA. 2004 Dec 8;292(22):2750-4
15585735